Medtronic Plc Valuation

<div class='circular--portrait' style='background:#8A0CCF;color: white;font-size:4em;padding-top: 15px;;'>ME</div>
MDT -- USA Stock  

Fiscal Quarter End: January 31, 2020  

Medtronic plc secures last-minute Real Value of $106.09 per share. The latest price of the firm is $121.04. At this time the firm appears to be overvalued. This module forecasts value of Medtronic plc from analyzing the firm fundamentals such as Current Valuation of 165.85 B, Profit Margin of 0.0017  and Return On Equity of 0.0018  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Overvalued
Today
121.04
January 22, 2020
103.60
Downside
106.09
Real Value
130.93
Upside
Medtronic Plc is very steady asset. Calculation of real value of Medtronic plc is based on 3 months time horizon. Increasing Medtronic plc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
Medtronic plc Valuation Data Drivers
Average Assets    Enterprise Value    Market Capitalization    

Medtronic Plc Market Cap

Medtronic plc is considered to be number one stock in market capitalization category among related companies. Market capitalization of Medical Devices industry is now estimated at about 193.97 Billion. Medtronic Plc totals roughly 148.71 Billion in market capitalization claiming about 77% of all equities under Medical Devices industry.
Capitalization  Workforce  Total debt  Revenue  Valuation
Horizon     30 Days    Login   to change
Medtronic plc is regarded second in price to earning category among related companies. It is regarded fourth in price to sales category among related companies fabricating about  0.14  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for Medtronic plc is roughly  7.01 

Valuation Basics

Medtronic Plc Enterprise Value Fundamentals

Quick Ratio2.02
Earnings Quarterly Growth22.30%
Revenue Growth3.00%
Payout Ratio60.29%
Enterprise Value To Ebitda18.60
Earnings Growth23.20%
Enterprise Value To Revenue5.70

Valuation Indicators

Medtronic Plc Valuation Fundamental Ratios

Additionally see Stocks Correlation. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Company logos by clearbit